Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells
Author:
Funder
Deanship of Scientific Research, King Saud University
King Khalid University
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference44 articles.
1. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor;Alam;Biomed. Pharmacother.,2017
2. 17The evolving role of antiangiogenic therapies in glioblastoma multiforme: Current clinical significance and future potential;Anthony;Expert Opin. Investig. Drugs,2019
3. PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation;Averineni;Bull. Mater. Sci.,2012
4. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties;Avgoustakis;J. Control. release,2002
5. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance;Bar-Zeev;Drug Resist. Updat.,2017
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment;Biomedicines;2024-08-11
2. Hyaluronic acid-functionalized graphene-based nanohybrids for targeted breast cancer chemo-photothermal therapy;International Journal of Pharmaceutics;2024-02
3. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles;Environmental Research;2024-01
4. Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response;Journal of Pharmaceutical and Biomedical Analysis;2024-01
5. Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma;Journal of Materials Chemistry B;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3